The Bulletin
Men's Weekly


.

Latest Updates of 6 Viva's Portfolio Companies

  • Written by PR Newswire

HONG KONG, April 4, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization.

Recently, 6 of Viva's...